Solos Technology Limited has filed a patent infringement lawsuit accusing Meta Platforms (NasdaqGS:META) of using its smart glasses technologies without authorization. The complaint targets Meta's use ...
Knobbe Martens’ 2025 Federal Circuit Year in Review report, covering over 50 of the most noteworthy patent-related Federal Circuit decisions ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...
Solos Technology Limited has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) over smart glasses ...
U.S. litigation funding firm Longford Capital and law firm Susman Godfrey have been sued by a patent monetization company ...
"One key issue that has arisen in funded patent litigation is transparency—in other words, to what extent must funder involvement in a patent infringement action be revealed? This article tackles this ...
This week on IPWatchdog Unleashed, we enter the patent litigation world for a conversation about gaming patent litigation. For too long, popular sentiment has been that patent owners are bad actors ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Judge Pauline Newman has served with distinction on the U.S. Court of Appeals for the Federal Circuit since her appointment ...
This case[1] involves an appeal from Regeneron Pharmaceuticals, Inc.’s (Regeneron) efforts to prevent defendants from marketing biosimilar versions of EYLEA®, a drug used to treat eye diseases, by ...
The Association for Accessible Medicines and the Biosimilars Council released a white paper, Serial Patent Litigation Problems and Solutions, which AAM said analyzes the increasingly common practices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results